Collier Financial »

Takeda Pharmaceutical shares owned by Collier Financial

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Collier Financial from 13F filings

Historical chart of Collier Financial investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Collier Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Collier Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $780 50 15.60
2025-09-30 $732 50 14.64
2025-03-31 $744 50 14.88
2024-12-31 $662 50 13.24

More positions owned by Collier Financial

State Street MF Closed and MF Open (SPYG)
State Street MF Closed and MF Open (SPTI)
State Street MF Closed and MF Open (SPYV)
State Street MF Closed and MF Open (SPMB)
State Street MF Closed and MF Open (SPIB)
Spdr Developed MF Closed and MF Open (SPDW)
State Street MF Closed and MF Open (SPSM)
Spdr Emerging MF Closed and MF Open (SPEM)
Invesco S&p MF Closed and MF Open (SPHQ)
S&p Global Common Stock (SPGI)
State Street MF Closed and MF Open (SLYG)
State Street MF Closed and MF Open (SPYM)
Ishares U S MF Closed and MF Open (GOVT)
State Street MF Closed and MF Open (BIL)
State Street MF Closed and MF Open (BILS)

View all positions for Collier Financial

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
FMR
UBS Group
Brandes Investment Partners
Toronto-Dominion Bank
BlackRock
Millennium Management
Renaissance Technologies
First Trust Advisors
Van Eck Associates Corp.
Northern Trust
Citadel Advisors
Managed Asset Portfolios

View all funds holding Takeda Pharmaceutical